You are searching for: hsa04061

---

T20178 Target Info	Target Name	Tumor necrosis factor (TNF)
	Target type	Successful Target
	Disease	Intermittent claudication; Multiple myeloma;
	Drugs	Adalimumab	Drug Info

T06955 Target Info	Target Name	C-C chemokine receptor type 4 (CCR4)
	Target type	Successful Target
	Disease	Mycosis fungoides; Sezary syndrome;
	Drugs	Mogamulizumab	Drug Info

T61698 Target Info	Target Name	Interleukin-2 (IL2)
	Target type	Successful Target
	Disease	Multiple sclerosis; Diabetic complication;
	Drugs	Aldesleukin	Drug Info

T96845 Target Info	Target Name	Interleukin-37 (IL37)
	Target type	Successful Target
	Disease	Plaque psoriasis;
	Drugs	Tildrakizumab	Drug Info

T16016 Target Info	Target Name	C-C chemokine receptor type 1 (CCR1)
	Target type	Clinical trial Target
	Disease	Autoimmune diabetes; Chronic obstructive pulmonary disease;
	Drugs	CCX-354	Drug Info

T89988 Target Info	Target Name	C-C chemokine receptor type 2 (CCR2)
	Target type	Clinical trial Target
	Disease	Diabetic nephropathy; Human immunodeficiency virus infection;
	Drugs	CCX-140	Drug Info

T96627 Target Info	Target Name	C-X-C motif chemokine 2 (CXCL2)
	Target type	Clinical trial Target
	Disease	Multiple sclerosis;
	Drugs	Laquinamod	Drug Info

T19579 Target Info	Target Name	Interleukin 2 receptor beta (IL2RB)
	Target type	Clinical trial Target
	Disease	Glioblastoma multiforme; Sarcoma;
	Drugs	NKTR 214	Drug Info

T06671 Target Info	Target Name	Interleukin-18 (IL18)
	Target type	Clinical trial Target
	Disease	XIAP deficiency; Type-2 diabetes;
	Drugs	Tadekinig alfa	Drug Info

T11309 Target Info	Target Name	Monocyte chemotactic and activating factor (CCL2)
	Target type	Clinical trial Target
	Disease	Nephritis; Diabetic complication;
	Drugs	Bindarit	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.